Keywords: Grunenthal, Ethyparm, Fentanyl sublingual, Ajinomoto, Althea Tech, Contract manufacturing, M&A, Alexion, Soliris, Atypical HUS, Canada

News briefs: Grunenthal adds to portfolio; Ajinomoto to buy Althea; Alexion's Soliris OKed in Canada

Article | 06 March 2013

Family-owned German drugmaker Grunenthal has concluded an exclusive license, distribution and supply agreement with Ethypharm, a French company that is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Ajinomoto

Ethypharm

Grunenthal

Althea Technologies

Alexion Pharmaceuticals

Go to company listing

Related Drugs

Soliris

fentanyl

Go to drug listing